APO RESEARCH · REPORT
Neurorehabilitation
Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system.
Product & engineering
Understand the product.
The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.
What turns activity into demand
Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.
The commercial boundary
For Neurorehabilitation, distinguish the supplied service or configured system from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.
Which conditions determine usable neurorehabilitation performance?
Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.
Selected research
Market Structure
Global Neurorehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Neurorehabilitation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Neurorehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Neurorehabilitation include VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH and Sun Java, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Neurorehabilitation market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Neurorehabilitation and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Neurorehabilitation revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Neurorehabilitation market size, projected growth trends, production technologies, key applications, and end-use industries.
Neurorehabilitation Segment by Company
VISHEE
Beijing Bo'ai Hospital
Beijing Rehabilitation Hospital of Capital Medical University
NCC
CHIEFTAIN
Tongji Hospital
Haobro Medical Device
DIH
Sun Java
Aoyang Health
PKUCare Rehabilitation Hospital
Beijing Puhua International Hospital
Xiangyu Medical
Beijing United Family Rehabilitation Hospital
Neurorehabilitation Segment by Type
Brain Injury
Spinal Cord Injury
Peripheral Nerve Injury
Other
Neurorehabilitation Segment by Application
General Hospital
Rehabilitation Specialist Hospital
Community Rehabilitation Center
Neurorehabilitation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Neurorehabilitation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurorehabilitation industry.
Chapter 3: Detailed analysis of Neurorehabilitation companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurorehabilitationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain Injury
- Spinal Cord Injury
- Peripheral Nerve Injury
- Other
Applications
- General Hospital
- Rehabilitation Specialist Hospital
- Community Rehabilitation Center
Companies covered
- VISHEE
- Beijing Bo'ai Hospital
- Beijing Rehabilitation Hospital of Capital Medical University
- NCC
- CHIEFTAIN
- Tongji Hospital
- Haobro Medical Device
- DIH
- Sun Java
- Aoyang Health
- PKUCare Rehabilitation Hospital
- Beijing Puhua International Hospital
- Xiangyu Medical
- Beijing United Family Rehabilitation Hospital
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Neurorehabilitation Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Brain Injury
- 1.2.3 Spinal Cord Injury
- 1.2.4 Peripheral Nerve Injury
- 1.2.5 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Neurorehabilitation Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 General Hospital
- 1.3.3 Rehabilitation Specialist Hospital
- 1.3.4 Community Rehabilitation Center
- 1.4 Global Market Growth Prospects
- 1.5 Global Neurorehabilitation Growth Trends by Region
- 1.5.1 Global Neurorehabilitation Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Neurorehabilitation Market Size by Region (2021-2026)
- 1.5.3 Neurorehabilitation Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Neurorehabilitation Market Dynamics
- 2.1 Neurorehabilitation Industry Trends
- 2.2 Neurorehabilitation Industry Drivers
- 2.3 Neurorehabilitation Industry Opportunities and Challenges
- 2.4 Neurorehabilitation Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Neurorehabilitation Revenue by Company (2021-2026)
- 3.2 Global Neurorehabilitation Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Neurorehabilitation Key Company Head office and Area Served
- 3.4 Global Neurorehabilitation Company, Product Type & Application
- 3.5 Global Neurorehabilitation Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Neurorehabilitation Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Neurorehabilitation Players Market Share by Revenue in 2025
- 3.6.3 2025 Neurorehabilitation Tier 1, Tier 2, and Tier 3
4 Neurorehabilitation Market by Type
- 4.1 Global Neurorehabilitation Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Neurorehabilitation Market Size by Type (2021-2032)
- 4.3 Global Neurorehabilitation Market Size Share by Type (2021-2032)
5 Neurorehabilitation Market by Application
- 5.1 Global Neurorehabilitation Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Neurorehabilitation Market Size by Application (2021-2032)
- 5.3 Global Neurorehabilitation Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 VISHEE
- 6.1.1 VISHEE Company Information
- 6.1.2 VISHEE Business Overview
- 6.1.3 VISHEE Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 VISHEE Neurorehabilitation Product Portfolio
- 6.1.5 VISHEE Recent Developments
- 6.2 Beijing Bo'ai Hospital
- 6.2.1 Beijing Bo'ai Hospital Company Information
- 6.2.2 Beijing Bo'ai Hospital Business Overview
- 6.2.3 Beijing Bo'ai Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio
- 6.2.5 Beijing Bo'ai Hospital Recent Developments
- 6.3 Beijing Rehabilitation Hospital of Capital Medical University
- 6.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Information
- 6.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
- 6.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio
- 6.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
- 6.4 NCC
- 6.4.1 NCC Company Information
- 6.4.2 NCC Business Overview
- 6.4.3 NCC Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 NCC Neurorehabilitation Product Portfolio
- 6.4.5 NCC Recent Developments
- 6.5 CHIEFTAIN
- 6.5.1 CHIEFTAIN Company Information
- 6.5.2 CHIEFTAIN Business Overview
- 6.5.3 CHIEFTAIN Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 CHIEFTAIN Neurorehabilitation Product Portfolio
- 6.5.5 CHIEFTAIN Recent Developments
- 6.6 Tongji Hospital
- 6.6.1 Tongji Hospital Company Information
- 6.6.2 Tongji Hospital Business Overview
- 6.6.3 Tongji Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Tongji Hospital Neurorehabilitation Product Portfolio
- 6.6.5 Tongji Hospital Recent Developments
- 6.7 Haobro Medical Device
- 6.7.1 Haobro Medical Device Company Information
- 6.7.2 Haobro Medical Device Business Overview
- 6.7.3 Haobro Medical Device Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Haobro Medical Device Neurorehabilitation Product Portfolio
- 6.7.5 Haobro Medical Device Recent Developments
- 6.8 DIH
- 6.8.1 DIH Company Information
- 6.8.2 DIH Business Overview
- 6.8.3 DIH Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 DIH Neurorehabilitation Product Portfolio
- 6.8.5 DIH Recent Developments
- 6.9 Sun Java
- 6.9.1 Sun Java Company Information
- 6.9.2 Sun Java Business Overview
- 6.9.3 Sun Java Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Sun Java Neurorehabilitation Product Portfolio
- 6.9.5 Sun Java Recent Developments
- 6.10 Aoyang Health
- 6.10.1 Aoyang Health Company Information
- 6.10.2 Aoyang Health Business Overview
- 6.10.3 Aoyang Health Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Aoyang Health Neurorehabilitation Product Portfolio
- 6.10.5 Aoyang Health Recent Developments
- 6.11 PKUCare Rehabilitation Hospital
- 6.11.1 PKUCare Rehabilitation Hospital Company Information
- 6.11.2 PKUCare Rehabilitation Hospital Business Overview
- 6.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio
- 6.11.5 PKUCare Rehabilitation Hospital Recent Developments
- 6.12 Beijing Puhua International Hospital
- 6.12.1 Beijing Puhua International Hospital Company Information
- 6.12.2 Beijing Puhua International Hospital Business Overview
- 6.12.3 Beijing Puhua International Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Beijing Puhua International Hospital Neurorehabilitation Product Portfolio
- 6.12.5 Beijing Puhua International Hospital Recent Developments
- 6.13 Xiangyu Medical
- 6.13.1 Xiangyu Medical Company Information
- 6.13.2 Xiangyu Medical Business Overview
- 6.13.3 Xiangyu Medical Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Xiangyu Medical Neurorehabilitation Product Portfolio
- 6.13.5 Xiangyu Medical Recent Developments
- 6.14 Beijing United Family Rehabilitation Hospital
- 6.14.1 Beijing United Family Rehabilitation Hospital Company Information
- 6.14.2 Beijing United Family Rehabilitation Hospital Business Overview
- 6.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio
- 6.14.5 Beijing United Family Rehabilitation Hospital Recent Developments
7 North America
- 7.1 North America Neurorehabilitation Market Size (2021-2032)
- 7.2 North America Neurorehabilitation Market Size by Type
- 7.2.1 North America Neurorehabilitation Market Size by Type (2021-2026)
- 7.2.2 North America Neurorehabilitation Market Size by Type (2027-2032)
- 7.2.3 North America Neurorehabilitation Market Share by Type (2021-2032)
- 7.3 North America Neurorehabilitation Market Size by Application
- 7.3.1 North America Neurorehabilitation Market Size by Application (2021-2026)
- 7.3.2 North America Neurorehabilitation Market Size by Application (2027-2032)
- 7.3.3 North America Neurorehabilitation Market Share by Application (2021-2032)
- 7.4 North America Neurorehabilitation Market Size by Country
- 7.4.1 North America Neurorehabilitation Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Neurorehabilitation Market Size by Country (2021-2026)
- 7.4.3 North America Neurorehabilitation Market Size by Country (2027-2032)
- 7.4.4 North America Neurorehabilitation Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Neurorehabilitation Market Size (2021-2032)
- 8.2 Europe Neurorehabilitation Market Size by Type
- 8.2.1 Europe Neurorehabilitation Market Size by Type (2021-2026)
- 8.2.2 Europe Neurorehabilitation Market Size by Type (2027-2032)
- 8.2.3 Europe Neurorehabilitation Market Share by Type (2021-2032)
- 8.3 Europe Neurorehabilitation Market Size by Application
- 8.3.1 Europe Neurorehabilitation Market Size by Application (2021-2026)
- 8.3.2 Europe Neurorehabilitation Market Size by Application (2027-2032)
- 8.3.3 Europe Neurorehabilitation Market Share by Application (2021-2032)
- 8.4 Europe Neurorehabilitation Market Size by Country
- 8.4.1 Europe Neurorehabilitation Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Neurorehabilitation Market Size by Country (2021-2026)
- 8.4.3 Europe Neurorehabilitation Market Size by Country (2027-2032)
- 8.4.4 Europe Neurorehabilitation Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Neurorehabilitation Market Size (2021-2032)
- 9.2 China Neurorehabilitation Market Size by Type
- 9.2.1 China Neurorehabilitation Market Size by Type (2021-2026)
- 9.2.2 China Neurorehabilitation Market Size by Type (2027-2032)
- 9.2.3 China Neurorehabilitation Market Share by Type (2021-2032)
- 9.3 China Neurorehabilitation Market Size by Application
- 9.3.1 China Neurorehabilitation Market Size by Application (2021-2026)
- 9.3.2 China Neurorehabilitation Market Size by Application (2027-2032)
- 9.3.3 China Neurorehabilitation Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Neurorehabilitation Market Size (2021-2032)
- 10.2 Asia Neurorehabilitation Market Size by Type
- 10.2.1 Asia Neurorehabilitation Market Size by Type (2021-2026)
- 10.2.2 Asia Neurorehabilitation Market Size by Type (2027-2032)
- 10.2.3 Asia Neurorehabilitation Market Share by Type (2021-2032)
- 10.3 Asia Neurorehabilitation Market Size by Application
- 10.3.1 Asia Neurorehabilitation Market Size by Application (2021-2026)
- 10.3.2 Asia Neurorehabilitation Market Size by Application (2027-2032)
- 10.3.3 Asia Neurorehabilitation Market Share by Application (2021-2032)
- 10.4 Asia Neurorehabilitation Market Size by Country
- 10.4.1 Asia Neurorehabilitation Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Neurorehabilitation Market Size by Country (2021-2026)
- 10.4.3 Asia Neurorehabilitation Market Size by Country (2027-2032)
- 10.4.4 Asia Neurorehabilitation Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Neurorehabilitation Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Neurorehabilitation Market Size by Type
- 11.2.1 South America, Middle East & Africa Neurorehabilitation Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Neurorehabilitation Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Neurorehabilitation Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Neurorehabilitation Market Size by Application
- 11.3.1 South America, Middle East & Africa Neurorehabilitation Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Neurorehabilitation Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Neurorehabilitation Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Neurorehabilitation Market Size by Country
- 11.4.1 South America, Middle East & Africa Neurorehabilitation Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Neurorehabilitation Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Neurorehabilitation Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Neurorehabilitation Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst